Adherence to Active Surveillance Protocols for Low-risk Prostate Cancer: Results of the Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance Initiative
Arveen Kalapara(Monash University), Artitaya Lophatananon(Manchester Academic Health Science Centre), Mieke Van Hemelrijck(Ghent University Hospital), Prokar Dasgupta(King's College London), Caroline M. Moore(University College London Hospitals NHS Foundation Trust), Christopher J. Logothetis(The University of Texas MD Anderson Cancer Center), Bruce J. Trock(Johns Hopkins University), Behfar Ehdaie(NewYork–Presbyterian Hospital), Anders Bjartell(Lund University), J. Rubio‐Briones, Byung Ha Chung, Jonas Hugosson(Sahlgrenska University Hospital), Daan Nieboer(Erasmus MC), Vincent J. Gnanapragasam(Addenbrooke's Hospital), Todd M. Morgan(University of Michigan), Jozien Helleman(Erasmus MC), Jeri Kim(The University of Texas MD Anderson Cancer Center), Lee Lui Shiong(Singapore General Hospital), Kenneth Muir(Manchester Academic Health Science Centre), Antti Rannikko(Royal Free London NHS Foundation Trust), Monique J. Roobol(Erasmus MC), Jan Verbeek(Erasmus MC), Michael Fahey, Tim Hulsen(Philips (Netherlands)), Arnauld Villers(Université de Lille), Peter R. Carroll(University of California, San Francisco), Theodorus van der Kwast(Erasmus MC), Mark Frydenberg(Monash University), Lukas Hefermehl, Tom Pickles, Henk Obbink, Cees de Jonge, Tim Harkin(Monash University), Laurence Klotz(University of Toronto), Antoinette S. Perry, Yoshiyuki Kakehi(Kagawa University), Lui Shiong Lee(Singapore General Hospital), Ewout W. Steyerberg(Erasmus MC), Christopher P. Filson(Emory University), Wim van der Linden(Philips (Netherlands)), Eric Hyndman, Chris H. Bangma(Erasmus MC), Xinge Ji(Cleveland Clinic), R. Valdagni
Cited by 37
Related Papers
Assessing the Performance of Prediction Models
|Epidemiology|2009|4.9k
Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal
|BMJ|2020|3.2k
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
|New England Journal of Medicine|2012|2.8k
Internal validation of predictive models
|Journal of Clinical Epidemiology|2001|2.6k
Towards better clinical prediction models: seven steps for development and an ABCD for validation
|European Heart Journal|2014|1.9k